Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 96 entries
View as:

Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Phase: N/A Priority: Normal
NCT ID: NCT06007989 Org: User:
Start: 11/01/23 End: 08/01/24 Due: 08/01/25

Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01926236 Org: User:
Start: 02/28/14 End: 01/31/19 Due: 01/31/20

A Study Using MRI To Assess Bladder Motion During Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03409029 Org: User:
Start: 03/31/18 End: 09/30/19 Due: 09/30/20

PDAC Peripheral and Portal Vein Sampling

Phase: N/A Priority: Normal
NCT ID: NCT04289961 Org: User:
Start: 06/12/19 End: 04/06/23 Due: 04/06/24

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Phase: N/A Priority: Normal
NCT ID: NCT00022178 Org: User:
Start: 12/31/98 End: - Due: -

Musculoskeletal Health in Adult Haematological Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05865678 Org: User:
Start: 05/02/23 End: 05/31/24 Due: 05/31/25

A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT01493453 Org: User:
Start: 03/31/08 End: 06/30/19 Due: 06/30/20

Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT04750109 Org: User:
Start: 06/09/21 End: 06/28/24 Due: 06/28/25

MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04749134 Org: User:
Start: 08/01/21 End: 01/31/26 Due: 01/31/27

A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03258788 Org: User:
Start: 01/03/19 End: 03/18/20 Due: 03/18/21

A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)

Phase: N/A Priority: Normal
NCT ID: NCT02507804 Org: User:
Start: 07/31/15 End: 06/03/19 Due: 06/03/20

Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04543045 Org: User:
Start: 05/05/21 End: 09/30/23 Due: 09/30/24

RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial

Phase: N/A Priority: Normal
NCT ID: NCT01127542 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study

Phase: N/A Priority: Normal
NCT ID: NCT04396119 Org: User:
Start: 02/11/20 End: 04/13/20 Due: 04/13/21

Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00022009 Org: User:
Start: 07/31/01 End: - Due: -

PLX3397 KIT in Acral aNd mucOsal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02071940 Org: User:
Start: 10/31/15 End: 03/02/21 Due: 03/02/22

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01921998 Org: User:
Start: 10/31/13 End: - Due: -

PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06322927 Org: User:
Start: 03/31/24 End: 09/30/24 Due: 09/30/25

Effect of Pegvisomant on GH/IGF-I Relationship in GHD

Phase: N/A Priority: Normal
NCT ID: NCT00468624 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Temozolomide in Treating Women With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005054 Org: User:
Start: 05/31/98 End: - Due: -

COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients

Phase: N/A Priority: Normal
NCT ID: NCT04852809 Org: User:
Start: 05/18/21 End: 03/10/22 Due: 03/10/23

Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01343121 Org: User:
Start: 02/02/12 End: 11/24/17 Due: 11/24/18

The CASCADE Project

Phase: N/A Priority: Normal
NCT ID: NCT06117592 Org: User:
Start: 03/01/24 End: 03/29/24 Due: 03/29/25

Remote Monitoring of Cancer Patients With Suspected Covid-19

Phase: N/A Priority: Normal
NCT ID: NCT04397705 Org: User:
Start: 10/12/20 End: 04/30/21 Due: 04/30/22

A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)

Phase: N/A Priority: Normal
NCT ID: NCT05903430 Org: User:
Start: 05/31/24 End: 03/31/27 Due: 03/31/28